期刊文献+

AMACR,WDR19与前列腺癌 被引量:1

下载PDF
导出
摘要 由于人口老龄化和环境污染,使各种肿瘤发病率普遍增高。据世界卫生组织预测。到2025年,全球将约有3亿人患癌症,并有2亿人因此死亡。我国癌症已列居各类死因之首,年均癌症新发病例约为200万人。上海地区前列腺癌发病率从1991年的2.9/10万迅速增长到2002年的12/10万,远远高于全国平均水平,成为上海10种最常见的恶性肿瘤之一。我国前列腺癌患者被确诊时,一半左右的病例已属晚期,大部分病例都有癌细胞转移,不仅失去了早期根治的机会,而且治疗预后情况很不理想,生存期也较国外的患者短。因此早诊断,早治疗是降低前列腺癌死亡率最有效的办法。
出处 《老年医学与保健》 CAS 2010年第4期252-254,共3页 Geriatrics & Health Care
  • 相关文献

参考文献12

二级参考文献61

  • 1顾琪.AMACR在前列腺癌中的表达和应用[J].肿瘤,2005,25(2):101-103. 被引量:3
  • 22001年上海市区恶性肿瘤发病率[J].肿瘤,2005,25(6):636-636. 被引量:8
  • 3Iczkowski KA, Jiang Z, Tretiakova M,et al.Prostatic needle biopsies with suspicious(ASAP) diagnosis: 80% resolved using P504S/AMACR and keration34E12 immunostaining.Mod Pathol, 2003,16:154A. 被引量:1
  • 4Jiang Z,Tretiakova M, Steinberg G, et al. Overexpression of Alpha- methylacyl CoA racemase/P504S in recurrent prostatic adenocarcinoma after radiation.Mod Pathol,2003,16:155A. 被引量:1
  • 5Kunju LP, Rubin MA, Shen R, et al. Comparison of monoclonal antibody(P504S) and polyclonal antibody to Alpha- methylacyl CoA racemase in benign atypical and malignant prostate tissue.Mod Pathol,2003,16:158A. 被引量:1
  • 6Abrahams N, Ormsby A, Brainard J. Cytokeratin 5/6 is a basal cell- specific marker in benign prostatic glandular proliferations and in prostate tissue with androgen deprivation effect.Mod Pathol,2002,15:150A. 被引量:1
  • 7Oliai BR, Kahne H, Epstein JI. High molecular weight cytokeratin reactivity in prostate cancinoma.Mod Pathol,2002,15:176A. 被引量:1
  • 8Varma M, Linden MD, Amin MB. Effect of formalin fixation and epitope retrieval techniques on antibody 34belaE12 immunostaining of prostatic tissues. Mod Pathol,1999,12:472- 478. 被引量:1
  • 9Gray W, Mckee GT(Ed). Diagnostic Cytopathology, Second Ed, Churchill Liningstone,2002,617- 627. 被引量:1
  • 10Rubin MA, Zhou M, Dhanasekaran SM, et al. Alpha- methylacyl CoA racemase as a tissue biomarker for prostate cancer.JAMA,2002,287:1662- 1670. 被引量:1

共引文献9

同被引文献14

  • 1戴文斌,宋建达.AMACR/P504S回顾与展望[J].临床泌尿外科杂志,2007,22(3):234-237. 被引量:10
  • 2Peyri Rcy E, Casalots Serramia J. Papillary cystadenoma of epididymis. Actas Urol Esp 2000; 24(9): 761-763. 被引量:1
  • 3Ferdinandusse S, Denis S, Ijist L, et al. Subcellular localization and physiological role of alpha-methylacyl-CoA racemose. JLipidRes 2000; 41(11): 1890-1896. 被引量:1
  • 4Zhou M, Chinnaiyan AM, Kleer CG. et al. Alpha- methylacyl-CoA racemase: a novel tumor marker over- expressed in several human cancers and their precursor lesions. Am JSurg Pathol 2002; 26(7): 926-931. 被引量:1
  • 5Zheng SL, Chang BI, Faith DA, et al. Sequence variants ofalpha-methylacyl-CoA racemase are associated with prostate cancer risk. Cancer Res 2002; 62(22): 6485- 6488. 被引量:1
  • 6Xu J, Stolk JA, Zhang X, et al. Identification of differentially expressed genes in human prostate cancer using subtraction and microarray. Cancer Res 2000; 60(6): 1677-1682. 被引量:1
  • 7Jiang Z, Woda BA, Rock KL, et al. P504S: a new molecular marker for the detection of prostate carcinoma. Am J Surg Patho12001; 25(11): 1397-1404. 被引量:1
  • 8Yang X J, Wu CL, Woda BA, et al. Expression ofalpha- Methylacyl-CoA racemase (P504S) in atypical adenomatous hyperplasia of the prostate. Am J Surg Patho12002: 26(7): 92 i-'925. 被引量:1
  • 9Rubin MA, Zhou M, Dhanasekaran SM, et al. alpha- Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. JAMA 2002; 287(13): 1662-1670. 被引量:1
  • 10Zhou M, Aydin H, Kanane H, et al. How often does alpha-methylacyl-CoA-racemase contribute to resolving an atypical diagnosis on prostate needle biopsy beyond that provided by basal cell markers? Am J Surg Pathol 2004; 28(2): 239-243. 被引量:1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部